Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Onswik

Pharmaceutical Executive Daily: FDA Approves Onswik

Published 1 month, 3 weeks ago
Description
InnoCare Pharma and Eli Lilly ink a multibillion-dollar research collaboration, FDA approves Lilly's once-weekly insulin Onswik for type 2 diabetes, and Jen Lamppa talks fixing clinical trial patient enrollment with real-world data.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us